Arbor Biotechnologies
Arbor Biotechnologies Raises $215M in Series C
Quick Facts
Arbor Biotechnologies Raises $215M in Series C
Arbor Biotechnologies has successfully raised $215M in a Series C at a $800M valuation led by Lightspeed Venture Partners, Redmile Group, Agent Capital, Amplitude Ventures.
Company Overview
Arbor Biotechnologies is a Biotech company headquartered in 830 Winter Street, Waltham, MA 02451, founded in 2016 with 100+ employees.
Gene editing technologies
Fundraising Details
- Amount Raised: $215M
- Round Type: Series C
- Valuation: $800M
- Date: 2024-11-28
- Investors: Lightspeed Venture Partners, Redmile Group, Agent Capital, Amplitude Ventures
About Arbor Biotechnologies
Gene editing technologies The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 830 Winter Street, Waltham, MA 02451
- Founded: 2016
- Team Size: 100+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Arbor Biotechnologies's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Arbor Biotechnologies's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $800M valuation marks an important milestone for Arbor Biotechnologies, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Arbor Biotechnologies is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-11-28. For more information about Arbor Biotechnologies, visit their headquarters at 830 Winter Street, Waltham, MA 02451.
About the Author
Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.
xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.
Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.